For the first time in its modern history, the prestigious Champagne appellation has authorized the use of a disease-resistant hybrid grape variety.
The grape, known as Voltis, represents a cautious but significant step toward adapting one of the world’s most tradition-bound wine regions to modern environmental and societal pressures.
A Historic Shift Backed by Science
Developed through collaboration between INRAE and the Julius Kühn Institute, Voltis was officially approved in late 2022 under the VIFA framework—France’s system for testing new grape varieties within appellations.
Unlike traditional hybrids, Voltis retains approximately 95% of its Vitis vinifera genetic makeup. This key threshold allowed French authorities to classify it as suitable for appellation wines, overcoming a major historical barrier against hybrid grapes.
Addressing Climate and Disease Pressures
Champagne’s cool, humid climate has long made it vulnerable to fungal diseases such as downy mildew and powdery mildew. These threats require frequent vineyard treatments, raising both environmental concerns and costs.
Voltis offers a practical solution. Its natural resistance to these fungi significantly reduces the need for plant protection products—especially important for vineyards located near residential areas or on steep, difficult-to-manage slopes.
According to Comité Champagne, the grape is not intended to replace traditional varieties but to complement them as part of a broader adaptation strategy.
Controlled Integration into the Appellation
The integration of Voltis into Champagne is deliberately cautious. Current regulations allow:
- Planting on up to 5% of vineyard surface
- Use of up to 10% in the final blend
This controlled approach ensures that the identity and style of Champagne wines remain intact while experimentation continues.
Early Vineyard Trials: Promising Results
Among the early adopters is Champagne Drappier, which planted Voltis vines in 2023 in the Côte des Bar. Notably, these vines were planted on Kimmeridgian soils, offering a different expression compared to earlier trials near Épernay.
The 2025 harvest yielded a small experimental batch—approximately 114 liters—but delivered encouraging results:
- No visible disease pressure
- Strong vine vigor
- Extended leaf vitality late into the season
This prolonged photosynthetic activity may enhance the vine’s ability to store reserves, potentially improving future yields and resilience.
A Neutral Profile, by Design
Initial tastings of Voltis-based wines suggest a relatively neutral aromatic profile. However, this is not seen as a drawback. In Champagne, blending is the cornerstone of winemaking, and neutrality can be an asset—allowing winemakers to build complexity and balance across cuvées.
Social and Environmental Impact
Beyond viticulture, Voltis addresses growing societal concerns. Producers like Champagne Lacroix have planted the variety near residential zones to reduce fungicide use and respond to public sensitivity around agricultural treatments.
For organic producers, Voltis may also reduce reliance on copper-based treatments—one of the few options permitted against downy mildew but increasingly restricted in France due to environmental concerns.
A Long-Term Experiment
The Champagne Committee has committed to a 10-year evaluation period to determine Voltis’ long-term role. Early feedback is encouraging: in blind tastings conducted in 2023 with nearly 700 experts, blends containing 5% Voltis were described as rounder, simpler, and more approachable.
Currently, around 170 experimental plots have been planted across cooperatives, maisons, and independent growers.
Beyond Voltis: A Broader Innovation Pipeline
Voltis is only the beginning. Two additional disease-resistant varieties—Aurelis and Cérélis—are under evaluation and could gain approval by 2027.
Meanwhile, the CEPINOV initiative is exploring nearly 400 experimental crosses involving Chardonnay and Pinot Noir to develop new resistant varieties tailored to both Champagne and Burgundy.
Tradition Still Matters
Despite this wave of innovation, Champagne remains deeply rooted in tradition. A recent example is the reauthorization of Chardonnay Rosé in 2025—a historic variety previously excluded due to administrative oversight.
Looking Ahead
The first commercial Champagnes containing Voltis are expected to reach the market between 2027 and 2028. In a region where vineyard practices evolve slowly—sometimes over centuries—this marks a carefully measured but meaningful shift.
For Champagne, the challenge is clear: preserve its identity while adapting to a changing world. Voltis may not redefine the region overnight, but it signals a willingness to innovate—without compromising the essence of what makes Champagne unique.
Source: Vinetur